What Are Cancer Genes and Mutations? Proto-Oncogenes and Tumor Suppressor Genes

Cancer Genes and Cancer Mutations

Genes are segments of genetic material that determine organisms' biological characteristics and regulate cell function: DNA sequences. A cancer gene is a gene that has undergone a mutation and plays a role in cancer development. These genes may cause tumor formation by promoting uncontrolled cell growth and division.

Cancer is a complex disease that develops through uncontrolled cell proliferation and spread. Genetic mutations are among the most fundamental drivers of this uncontrolled growth. Understanding cancer development at the cellular level requires a focus on proto-oncogenes and tumor suppressor genes . This article examines their structure and functions in detail, along with the effects of mutations in these genes on cancer development.

The figure above summarizes the roles of proto-oncogenes and tumor suppressor genes in cancer development. In normal cells, growth is controlled by a balance between factors that promote growth and those that inhibit or suppress it. Proto-oncogenes support cell growth, whereas tumor suppressor genes control and regulate it. The figure shows that mutations in these genes can result in loss or gain of function. Gain-of-function mutations make proto-oncogenes overactive and cause uncontrolled cell growth through dominant effects. Loss-of-function mutations reduce the activity of tumor suppressor genes, removing their ability to control cell growth. These mutations are generally recessive and require mutations in both alleles. This is known as the two-hit hypothesis in cancer genetics.

What Are Proto-Oncogenes and How Do They Work?

Proto-oncogenes are genes needed for normal cell growth, division and survival. They produce proteins that regulate growth and proliferation throughout the cell cycle. Their function is normally balanced, but mutations or structural changes can turn them into cancer-causing genes called oncogenes.

How Proto-Oncogenes Become Oncogenes: Proto-oncogenes generally become oncogenes through the following mechanisms:

• Point Mutations: A change in a single base pair may increase the function of the protein produced by a gene, causing uncontrolled cell proliferation. For example, point mutations in the RAS gene cause the protein to remain continuously active, leading cells to grow uncontrollably and form tumors.

• Gene Amplification: An increase in the number of proto-oncogene copies causes excessive protein production and uncontrolled cell size and proliferation. For example, amplification of the HER2 gene contributes to breast cancer progression.

• Chromosomal Translocations: The exchange of genetic material between different chromosomes can create new, abnormal gene combinations. This causes uncontrolled activation of proto-oncogenes. For example, the Philadelphia chromosome (BCR-ABL) translocation occurs in chronic myeloid leukemia (CML).

Tumor Suppressor Genes and the Fight Against Cancer

Tumor suppressor genes control cell growth and division and prevent cancer development. They govern critical mechanisms such as cell cycle arrest, DNA repair and apoptosis (programmed cell death). Mutations in these genes cause these protective mechanisms to lose their function, leading to uncontrolled proliferation.

Examples of Tumor Suppressor Genes:

• TP53: Known as the "guardian of the genome," TP53 regulates cell division. When DNA is damaged, it stops the cell cycle to allow repair or initiates apoptosis if the damage cannot be repaired. TP53 mutations allow cells to continue dividing despite DNA damage, causing tumor formation.

• RB1: The retinoblastoma protein (Rb protein) controls the cell cycle in the G1 phase, regulating progression to the S phase. RB1 gene mutations disrupt cell cycle control and may trigger retinoblastoma and other cancers.

• BRCA1/2: These genes are involved in DNA repair, and their mutations increase the risk of cancers such as breast, ovarian and prostate cancer.

The Two-Hit Hypothesis

Another important concept frequently discussed in cancer development is the two-hit hypothesis. Particularly associated with tumor suppressor gene mutations, it states that both copies (alleles) of a gene must acquire mutations for a cell to gain a growth advantage. For example, in the RB1 gene, the first mutation may be inherited, while the second arises somatically during life. This completely disrupts cellular control mechanisms and leads to tumor development.

The Effects of Mutations: Gain and Loss of Function

• Gain-of-Function Mutations: Increase a gene's protein expression or activity, causing uncontrolled cell proliferation. These mutations, occurring in a single allele, are generally dominant.

• Loss-of-Function Mutations: Cause a gene to lose its function, disabling mechanisms that control cell growth. They are generally recessive and must occur in both copies of the gene.

In genes encoding DNA repair mechanisms, loss-of-function mutations can allow cellular mutations to accumulate undetected and cancer to progress rapidly. For example, impaired DNA repair increases mutation accumulation and can make cancer more aggressive.

Comparing Proto-Oncogenes and Tumor Suppressor Genes

Proto-oncogenes and tumor suppressor genes have opposing functions that provide control over cell size and the cell cycle. Proto-oncogenes promote growth and proliferation, while tumor suppressor genes limit these processes and allow healthy cellular function. Mutations in proto-oncogenes lead to uncontrolled growth, whereas mutations in tumor suppressor genes allow the cell cycle to continue unchecked and genetic damage to accumulate.

The Importance of Proto-Oncogenes and Tumor Suppressor Genes in Cancer Treatment

Identifying mutations in proto-oncogenes and tumor suppressor genes enables personalized approaches to cancer treatment. For example, in HER2-positive breast cancer, targeted therapies such as trastuzumab produce effective results in patients with HER2 gene amplification. Similarly, detecting TP53 mutations is critical for predicting treatment response and selecting appropriate strategies. Treatments that restore tumor suppressor gene function or suppress oncogene activity play a major role in stopping cancer progression.

Conclusion

Proto-oncogenes and tumor suppressor genes are important parts of cancer's genetic foundations and help maintain balanced cellular function. Mutations in these genes are fundamental factors in cancer initiation and progression. Understanding these genetic mechanisms contributes to the development of more effective and personalized treatments. This knowledge is highly important for both early diagnosis and treatment.